Drug Shortage Report for HUMATROPE

Last updated on 2022-12-09 History
Report ID 168055
Drug Identification Number 02243079
Brand name HUMATROPE
Common or Proper name Somatropin for injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) SOMATROPIN DILUENT
Strength(s) 24MG 3.15ML
Dosage form(s) POWDER FOR SOLUTION LIQUID
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size Combination package containing 24 mg humatrope sterile lyophilized powder in a 3.5 mL cartridge and 3.15 mL prefilled diluent syringe
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-12-08
Actual start date 2022-12-08
Estimated end date 2023-04-28
Actual end date
Shortage status Actual shortage
Updated date 2022-12-09
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-12-09 English Compare
v15 2022-12-08 French Compare
v14 2022-12-08 English Compare
v13 2022-11-29 French Compare
v12 2022-11-29 English Compare
v11 2022-11-22 French Compare
v10 2022-11-22 English Compare
v9 2022-11-19 English Compare
v8 2022-11-18 French Compare
v7 2022-11-18 English Compare
v6 2022-11-01 French Compare
v5 2022-11-01 English Compare
v4 2022-09-13 French Compare
v3 2022-09-13 English Compare
v2 2022-08-26 French Compare
v1 2022-08-26 English Compare

Showing 1 to 16 of 16